Pulike Biological Engineering, Inc. (603566.SS)
CNY 13.78
(1.32%)
CNY 13.78
(1.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 571.28 Million CNY | -0.43% |
| 2022 | 549.43 Million CNY | 23.24% |
| 2021 | 445.81 Million CNY | 18.94% |
| 2020 | 374.81 Million CNY | 21.23% |
| 2019 | 309.18 Million CNY | 9.92% |
| 2018 | 281.27 Million CNY | 3.25% |
| 2017 | 272.41 Million CNY | 8.78% |
| 2016 | 250.42 Million CNY | 25.25% |
| 2015 | 199.94 Million CNY | 1.21% |
| 2014 | 197.54 Million CNY | 12.59% |
| 2013 | 175.45 Million CNY | 16.61% |
| 2012 | 150.45 Million CNY | 1.38% |
| 2011 | 148.4 Million CNY | 30.98% |
| 2010 | 113.3 Million CNY | 40.05% |
| 2009 | 80.9 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 139.98 Million CNY | 55.56% |
| 2024 Q1 | 117.75 Million CNY | -32.32% |
| 2024 Q2 | 90.34 Million CNY | -23.28% |
| 2023 Q2 | 126.43 Million CNY | 15.36% |
| 2023 Q4 | 173.99 Million CNY | 26.96% |
| 2023 FY | 547.08 Million CNY | -0.43% |
| 2023 Q3 | 137.05 Million CNY | 8.39% |
| 2023 Q1 | 109.6 Million CNY | -44.92% |
| 2022 Q3 | 138.71 Million CNY | 30.7% |
| 2022 FY | 549.43 Million CNY | 23.24% |
| 2022 Q4 | 198.98 Million CNY | 43.45% |
| 2022 Q1 | 105.6 Million CNY | -16.59% |
| 2022 Q2 | 106.12 Million CNY | 0.49% |
| 2021 Q4 | 126.61 Million CNY | 17.57% |
| 2021 FY | 445.81 Million CNY | 18.94% |
| 2021 Q1 | 107.24 Million CNY | -10.26% |
| 2021 Q3 | 107.69 Million CNY | 3.31% |
| 2021 Q2 | 104.25 Million CNY | -2.79% |
| 2020 Q2 | 79.07 Million CNY | 26.35% |
| 2020 Q1 | 62.58 Million CNY | -39.87% |
| 2020 FY | 374.81 Million CNY | 21.23% |
| 2020 Q3 | 111.73 Million CNY | 41.29% |
| 2020 Q4 | 119.49 Million CNY | 6.95% |
| 2019 Q1 | 86.62 Million CNY | -11.09% |
| 2019 FY | 309.18 Million CNY | 9.92% |
| 2019 Q3 | 60.61 Million CNY | 6.28% |
| 2019 Q4 | 104.08 Million CNY | 71.7% |
| 2019 Q2 | 57.03 Million CNY | -34.16% |
| 2018 Q1 | 60.05 Million CNY | -24.9% |
| 2018 FY | 281.27 Million CNY | 3.25% |
| 2018 Q3 | 61.95 Million CNY | 1.83% |
| 2018 Q2 | 60.84 Million CNY | 1.32% |
| 2018 Q4 | 97.42 Million CNY | 57.24% |
| 2017 Q4 | 79.96 Million CNY | 13.76% |
| 2017 FY | 272.41 Million CNY | 8.78% |
| 2017 Q3 | 70.29 Million CNY | 14.61% |
| 2017 Q2 | 61.33 Million CNY | 1.46% |
| 2017 Q1 | 60.45 Million CNY | -25.58% |
| 2016 Q2 | 53.11 Million CNY | -0.9% |
| 2016 FY | 250.42 Million CNY | 25.25% |
| 2016 Q4 | 81.22 Million CNY | 30.1% |
| 2016 Q3 | 62.43 Million CNY | 17.55% |
| 2016 Q1 | 53.59 Million CNY | -6.88% |
| 2015 FY | 199.94 Million CNY | 1.21% |
| 2015 Q4 | 57.55 Million CNY | 16.12% |
| 2015 Q3 | 49.56 Million CNY | 14.5% |
| 2015 Q2 | 43.28 Million CNY | -12.59% |
| 2015 Q1 | 49.52 Million CNY | -4.48% |
| 2014 Q1 | -80.11 Million CNY | 0.0% |
| 2014 Q4 | 51.84 Million CNY | 6.08% |
| 2014 Q3 | 48.87 Million CNY | 391.08% |
| 2014 Q2 | -16.79 Million CNY | 79.04% |
| 2014 FY | 197.54 Million CNY | 12.59% |
| 2013 FY | 175.45 Million CNY | 16.61% |
| 2012 FY | 150.45 Million CNY | 1.38% |
| 2011 FY | 148.4 Million CNY | 30.98% |
| 2010 FY | 113.3 Million CNY | 40.05% |
| 2009 FY | 80.9 Million CNY | 0.0% |